GAMMA Investing’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
HP
YIH
PFSRSONJ
CUAMC
PR
EC
AA
GAMMA Investing's IRON Position: Q2 2026 in Review
GAMMA Investing increased its Disc Medicine (IRON) stake by 9% in Q2 2026, buying an estimated $1.65K and bringing the position to 292 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2806.
GAMMA Investing first reported a position in IRON in Q1 2024 and has held it in 10 quarters since. The position peaked at $24.1K in Q4 2025. 21 funds tracked by Wall St. Rank hold IRON as of Q2 2026.
- GAMMA Investing held 292 shares of Disc Medicine worth $21.4K as of Q2 2026.
- GAMMA Investing bought 24 Disc Medicine shares in Q2 2026, an estimated $1.65K.
- Disc Medicine made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2806 holding.
- GAMMA Investing first reported a position in Disc Medicine in Q1 2024 and has held it in 10 quarters since.
- GAMMA Investing's Disc Medicine position peaked at $24.1K in Q4 2025.
- 21 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.
Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.